MedTrace Logo

Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser

NCT03143192 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2019-09-10

No results posted yet for this study

Summary

The goal of this pilot study is to investigate the safety and efficacy of micropulse (MP) macular laser in combination with intravitreal aflibercept for the treatment of centre-involved diabetic macular edema.

Conditions

Interventions

COMBINATION_PRODUCT

Micropulse Laser

Aflibercept injection with Micropulse laser.

DEVICE

Sham Laser

Aflibercept injection with Sham Laser

Sponsors & Collaborators

  • Keyvan Koushan

    lead OTHER

Principal Investigators

  • Keyvan Koushan, MD, FRCSC · Toronto Retina Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-08
Primary Completion
2019-05-09
Completion
2019-05-09

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03143192 on ClinicalTrials.gov